Protein release from biodegradable poly(lactide-co-glycolide) matrices: Does the swelling of implants influence the in vitro release kinetics?

S.T.P. Pharma Sciences

Volumn 9, Issue 5, 1999, Pages 487-495

  Witt, C ^a   Traechslin, E ^a   Kissel, T ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Implant; Poly(lactide co glycolide); Protein release; Swelling properties

Indexed keywords

BOVINE SERUM ALBUMIN; M PROTEIN; POLYGLACTIN;

ARTICLE; BIODEGRADATION; CONTROLLED DRUG RELEASE; DRUG IMPLANT; MACROMOLECULE; MOLECULAR DYNAMICS; SCANNING ELECTRON MICROSCOPY;

EID: 0033298851     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems
2. In vivo biocompatibility of implantable delivery systems and biomaterials
3. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers
4. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems
5. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres
6. Poly(DL-lactide-co-glycolide) encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration
7. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems
8. Parenteral depot-systems on the basis of biodegradable polyesters
9. Microencapsulation of rh-erythropoietin, using biodegradable poly(D, L-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients
10. Erosion kinetics of hydrolytically degradable polymers
11. Polymer degradation and erosion: Mechanisms and applications
12. Poly(glycolic acid-co-DL-lactic acid): Diffusion or degradation controlled drug delivery
13. Bioresorbable polymers for temporary therapeutic applications
14. Mechanistic studies of macromolecular drug release from macroporous polymers. II. Models for the slow kinetics of drug release
15. Microencapsulation using poly(L-lactic acid). III. Effect of polymer molecular weight on the microcapsule properties
16. Bovine serum albumin release from poly(a-hydroxy acid) microspheres: Effects of polymer molecular weight and surface properties
17. Controlled release of albumin from biodegradable poly(DL-lactide) cylinders
18. Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue
19. In vitro controlled release of isoniazid from poly(lactide-co-glycolide) matrices
20. Biodegradable polymers for the sustained release of peptides
21. Controlled release of polypeptides and other macromolecules
22. Controlled release of proteins from dextran hydrogels
23. ESR-Untersuchungen zur Wasserpenetration in Polymerfolien und Mikropartikeln auf der Basis von biologisch abbaubaren Polyestern
24. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres
25. Mechanism of sustained-action medication
26. Investigation of factors influencing the release of solid drug dispersed in inert matrices. II
27. Freeze-fracturing for conventional and field emission low-temperature scanning electron microscopy: The scanning cryo unit SCU 020
28. Swelling - The force that disintegrates
29. Permeability and release properties of biodegradable polymers
30. Serum albumin
31. Diffusional release of water-soluble bioactive agents from ethylene-vinyl acetate copolymers
32. Polymers for sustained macromolecule release: Procedures to fabricate reproducible delivery systems and control release kinetics
33. Biodegradable polymers for use in surgery- (polyglycolic/polylactic acid) homo- and copolymers. 1